AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcus Biosciences, Inc. Director's Dealing 2019

Oct 4, 2019

31966_dirs_2019-10-04_eb47549b-1065-4cc4-bb01-d1c413af296d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2019-10-01

Reporting Person: Barker Jason (See Remarks)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$8.01	2029-06-08	Common Stock (150000)		Direct

Footnotes

F1: The option is exercisable in 48 equal monthly installments after May 30, 2019, subject to the reporting person's continued service to the Company.